Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer

New therapeutic developments aimed at treating women with advanced breast cancer currently focus both on identifying patients eligible for targeted therapeutic concepts and on the continuing development of immune therapies. The data on CDK4/6 inhibitors are now complete and consistent in this class...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Volkmar, Wöckel, Achim, Lux, Michael P., Janni, Wolfgang, Hartkopf, Andreas D., Nabieva, Naiba, Taran, Florin-Andrei, Hadji, Peyman, Tesch, Hans, Ettl, Johannes, Lüftner, Diana, Welslau, Manfred, Belleville, Erik, Brucker, Sara Y., Schütz, Florian, Fasching, Peter A., Fehm, Tanja N., Kolberg, Hans-Christian, Schneeweiss, Andreas, Overkamp, Friedrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255740/
https://www.ncbi.nlm.nih.gov/pubmed/30498279
http://dx.doi.org/10.1055/a-0715-2899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255740/
https://www.ncbi.nlm.nih.gov/pubmed/30498279
http://dx.doi.org/10.1055/a-0715-2899

Ejemplares similares